Colin Mann
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
- Viral Infections and Vectors 3
- Viral Infections and Outbreaks Research 2
- COVID-19 Clinical Research Studies 2
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Galit Alter (4 shared papers)Erica Ollmann Saphire (4 shared papers)Jiang Zhu (4 shared papers)Xiaohe Lin (4 shared papers)Linling He (4 shared papers)Stephanie Fischinger (3 shared papers)Deniz Cizmeci (2 shared papers)Elon R. Musk (2 shared papers)
- Journals
- Cell Reports (2 papers)mBio (2 papers)Science Advances (2 papers)Science Translational Medicine (2 papers)Nature Communications (1 paper)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Colin Mann
18 papers receiving 453 citations
Peers
Comparison fields: 5 of 60
- Infectious Diseases 252
- Virology 59
- Immunology 112
- Hepatology 32
- Radiology, Nuclear Medicine and Imaging 92
Countries citing papers authored by Colin Mann
This map shows the geographic impact of Colin Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Mann more than expected).
Fields of papers citing papers by Colin Mann
This network shows the impact of papers produced by Colin Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Mann. The network helps show where Colin Mann may publish in the future.
Co-authors
The 25 scholars most cited alongside Colin Mann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 87 | |
| 2 | 2022 | 79 | |
| 3 | 2018 | 62 | |
| 4 | 2022 | 61 | |
| 5 | 2020 | 46 | |
| 6 | 2022 | 22 | |
| 7 | 2017 | 21 | |
| 8 | Efficacy and safety of once-daily levobunolol for glaucoma therapy. | 1989 | 16 |
| 9 | 2017 | 15 | |
| 10 | 2024 | 14 | |
| 11 | 1988 | 14 | |
| 12 | 2023 | 12 | |
| 13 | 2023 | 3 | |
| 14 | 2021 | 3 | |
| 15 | Use of suprathreshold test data to predict the results of quantitative testing in the nasal periphery. | 1990 | 2 |
| 16 | 2025 | 1 | |
| 17 | 2020 | 1 | |
| 18 | Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for all infants born in high-burden settings | 2022 | 1 |
About Colin Mann
Colin Mann is a scholar working on Infectious Diseases, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Virology and Ophthalmology, having authored 18 papers that have together received 460 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers), HIV Research and Treatment (4 papers), Glaucoma and retinal disorders (3 papers), Viral Infections and Vectors (3 papers), Hepatitis B Virus Studies (2 papers), Viral Infections and Outbreaks Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Infectious Diseases (252 citations), Virology (59 citations), Immunology (112 citations), Hepatology (32 citations) and Radiology, Nuclear Medicine and Imaging (92 citations). Colin Mann has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Galit Alter, Erica Ollmann Saphire, Jiang Zhu, Xiaohe Lin, Linling He, Stephanie Fischinger, Deniz Cizmeci, Elon R. Musk, Eric J. Nilles and Fatima Amanat. Their work appears in journals such as Cell Reports, mBio, Science Advances, Science Translational Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.